NO2874604T3 - - Google Patents

Info

Publication number
NO2874604T3
NO2874604T3 NO13747452A NO13747452A NO2874604T3 NO 2874604 T3 NO2874604 T3 NO 2874604T3 NO 13747452 A NO13747452 A NO 13747452A NO 13747452 A NO13747452 A NO 13747452A NO 2874604 T3 NO2874604 T3 NO 2874604T3
Authority
NO
Norway
Application number
NO13747452A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO2874604T3 publication Critical patent/NO2874604T3/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/69Boron compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/51Chelating agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO13747452A 2012-07-18 2013-07-17 NO2874604T3 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1256939A FR2993466B1 (fr) 2012-07-18 2012-07-18 Utilisation d'une creme de protection contre les effets des agents chimiques agressifs en contact avec la peau
PCT/FR2013/051718 WO2014013195A1 (fr) 2012-07-18 2013-07-17 Utilisation d'un agent chelatant amphotere pour prevenir les allergies de contact

Publications (1)

Publication Number Publication Date
NO2874604T3 true NO2874604T3 (no) 2018-07-14

Family

ID=47137836

Family Applications (1)

Application Number Title Priority Date Filing Date
NO13747452A NO2874604T3 (no) 2012-07-18 2013-07-17

Country Status (18)

Country Link
US (3) US11197874B2 (no)
EP (2) EP2874604B1 (no)
CN (4) CN110179686A (no)
AU (2) AU2013291792B2 (no)
BR (2) BR112015001019B1 (no)
CA (2) CA2878882C (no)
DK (2) DK2874661T3 (no)
ES (2) ES2690060T3 (no)
FR (1) FR2993466B1 (no)
IN (1) IN2014DN10924A (no)
MX (2) MX359747B (no)
NO (1) NO2874604T3 (no)
NZ (2) NZ703409A (no)
PL (2) PL2874661T3 (no)
PT (1) PT2874604T (no)
SI (1) SI2874661T1 (no)
TR (1) TR201815143T4 (no)
WO (2) WO2014013195A1 (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3093001B1 (fr) * 2019-02-22 2022-06-10 Prevor Int Composition pour enlever des residus chimiques et ses utilisations

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2604900B1 (fr) 1986-10-08 1989-01-13 Blomet Marie Claude Solution physiologique pour le lavage des parties du corps humain ayant ete mises en contact avec un acide fluorhydrique et concentre pour sa preparation
US5091171B2 (en) * 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
US5587400A (en) * 1993-04-19 1996-12-24 Marie-Claude Blomet epouse Meyer Physiological composition for the treatment of thermal or chemical burns
US5665804A (en) * 1996-02-05 1997-09-09 Dow Corning Corporation Silicone latex solvent thickening
SE9604610D0 (sv) * 1996-12-16 1996-12-16 Noviscens Ab Medical composition
US6242042B1 (en) * 1998-09-14 2001-06-05 Lrc Products Ltd. Aqueous coating composition and method
US6582683B2 (en) * 2000-01-04 2003-06-24 Skinvisible Pharmaceuticals, Inc. Dermal barrier composition
FR2809959B1 (fr) * 2000-06-07 2004-10-29 Marie Claude Meyer Utilisation d'un complexe d'aluminium et de ligand ethylenediamine-tetraacetique pour la prevention et/ou le traitement des urticaires
GB0403702D0 (en) * 2004-02-19 2004-03-24 Boots Co Plc Skincare compositions
JP2007508363A (ja) * 2003-10-14 2007-04-05 オキサジェン リミテッド Crth2アンタゴニスト活性を有する化合物
GB0324084D0 (en) * 2003-10-14 2003-11-19 Oxagen Ltd Compounds
US20090019224A1 (en) * 2005-02-02 2009-01-15 Pocrass Alan L Data Storage and Transfer Device and Method
MY161558A (en) * 2008-01-18 2017-04-28 Vystar Corp Natural rubber latex having reduced allergenicity and method of making
EP2482807A4 (en) * 2009-10-02 2013-04-24 Brigham & Womens Hospital COMPOSITIONS AND METHODS FOR PROPHYLAXIS FOR CONTACT ECZEMA

Also Published As

Publication number Publication date
US20210275553A1 (en) 2021-09-09
EP2874604A1 (fr) 2015-05-27
IN2014DN10924A (no) 2015-09-18
DK2874661T3 (en) 2018-11-05
CN104470501A (zh) 2015-03-25
MX356811B (es) 2018-06-13
CA2878882C (fr) 2020-08-18
TR201815143T4 (tr) 2018-11-21
FR2993466B1 (fr) 2014-08-15
BR112015001019B1 (pt) 2022-07-19
NZ703409A (en) 2016-11-25
ES2667709T3 (es) 2018-05-14
PL2874661T3 (pl) 2018-12-31
PT2874604T (pt) 2018-05-11
MX359747B (es) 2018-10-08
BR112015001019A2 (pt) 2017-06-27
US20150202217A1 (en) 2015-07-23
CN110179686A (zh) 2019-08-30
MX2015000785A (es) 2015-09-16
CA2878882A1 (fr) 2014-01-23
NZ703258A (en) 2016-11-25
US11197874B2 (en) 2021-12-14
AU2013291793B2 (en) 2017-11-23
EP2874661A1 (fr) 2015-05-27
DK2874604T3 (en) 2018-05-22
AU2013291792B2 (en) 2017-11-09
CA2878650C (fr) 2020-07-21
EP2874661B1 (fr) 2018-08-08
CA2878650A1 (fr) 2014-01-23
WO2014013194A1 (fr) 2014-01-23
AU2013291793A1 (en) 2015-01-22
AU2013291792A1 (en) 2015-01-22
WO2014013195A1 (fr) 2014-01-23
PL2874604T3 (pl) 2018-07-31
SI2874661T1 (sl) 2018-11-30
US10953024B2 (en) 2021-03-23
US20150190357A1 (en) 2015-07-09
BR112015001018A2 (pt) 2017-06-27
EP2874604B1 (fr) 2018-02-14
CN104507501A (zh) 2015-04-08
ES2690060T3 (es) 2018-11-19
MX2015000786A (es) 2015-09-16
BR112015001018B1 (pt) 2021-09-08
FR2993466A1 (fr) 2014-01-24
CN108606964A (zh) 2018-10-02

Similar Documents

Publication Publication Date Title
BR112014017635A2 (no)
BR112014019699A2 (no)
BR112014017592A2 (no)
BR112014017625A2 (no)
BR112014017659A2 (no)
BR112014020055A2 (no)
BR112014017646A2 (no)
BR112014017638A2 (no)
BR112014018648A2 (no)
BR112014017607A2 (no)
BR112013027865A2 (no)
BR112014017634A2 (no)
BR112014017644A2 (no)
BR112014017647A2 (no)
BR112014017588A2 (no)
BR112014017618A2 (no)
BR112014013184A8 (no)
BR112014017630A2 (no)
BR112014017652A2 (no)
BR112014017621A2 (no)
BR112014017622A2 (no)
BR112014017627A2 (no)
BR112014017623A2 (no)
BR112014019730A2 (no)
BR112014017641A2 (no)